Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients-Reference-Cited by-同舟云学术

Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients

Published:2018-01-24 Issue:8 Volume:20 Page:1072-1079
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Garde-Noguera J.^ORCID,Martin-Martorell P.,De Julián M.,Perez-Altozano J.,Salvador-Coloma C.,García-Sanchez J.,Insa-Molla A.,Martín M.,Mielgo-Rubio X.,Marin-Liebana S.,Blasco-Cordellat A.,Blasco-Molla S.,Gironés R.,Marquez-Medina D.,Aparisi F.,Cerda M. C. Bas,Macia-Escalante S.,Sánchez A.,Juan-Vidal O.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s12094-017-1829-5/fulltext.html

Reference16 articles.

1. International Agency for Research on Cancer (IARC). Latest world. Cancer Statistics. IARC, Lyon, France; 2013.

2. Berrino F. The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol. 2003;14(Suppl 5):v9–13.

3. Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5(1):29–33.

4. Cufer T, Ovcaricek T, O’Brien ME. Systemic therapy of advanced non-small cell lung cancer: major-developments of the last 5-years. Eur J Cancer. 2013;49(6):1216–25.

5. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355(24):2542–50.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review);International Journal of Oncology;2024-02-13

2. Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis;Therapeutic Advances in Medical Oncology;2024-01

3. Sequential Treatment of Anti-Pd-L1 Therapy Prior to Anti-Vegfr2 Therapy Contributes to More Significant Clinical Benefits in Non-Small Cell Lung Cancer;2024

4. Adaptive Designs for Precision Medicine in Clinical Trials: A Review and Some Innovative Designs;ICSA Book Series in Statistics;2024

5. Impact of bone metastasis on the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Clinical and Translational Oncology;2023-08-11